Trials / NCT03772938
Stem Cells Therapy in Degenerative Diseases of the Retina
Status unknown Phase 1 Cell therapy
- Sponsor
- Pomeranian Medical University Szczecin
- Treatment
- Stem/progenitor cells transplantation
- Gene
- Not stated
- Conditions
- Retinal Degeneration, Retinitis Pigmentosa, Age Related Macular Degeneration, Stargardt Disease 1
- Ages
- 18 Years to 65 Years
- Enrollment
- 30 participants
- Started
- 2018-12-13
- Main results expected
- 2020-02-28
- Results posted
- Not yet
- Record last updated
- 2018-12-17
What the study is testing
The purpose of this study is to test the safety and effectiveness of an autologous bone marrow-derived stem/progenitor cells administered intravitreously in the subjects with degenerative diseases of the retina.
Where it runs
Poland (1)
- I Department of Ophthalmology, Szczecin